ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 715778 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 715778; 2) Community: the network communities that were significantly associated with the response to NSC 715778; 3) Molecule: the relationships between components within communities and NSC 715778; 4) MDR: the compounds that were significantly associated with the NSC 715778.

NSC Compound Enrichment Correlation
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0430505868034764 0.28810083
NSC 751830 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one 0.0430505868034764 -0.26943575
NSC 758662 Lovastatin [USAN] 0.0430505868034764 -0.30050213
NSC 114512 Null 0.0435808621943462 0.32357486
NSC 139105 Soluble Baker's Antifol 0.0435808621943462 0.37709537
NSC 255104 Des-O-methylgeldanamycin 0.0435808621943462 0.47465376
NSC 292206 RUSTAIYAN A 0.0435808621943462 0.5497396
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 0.0435808621943462 0.19457388
NSC 30916 MP 317 0.0435808621943462 0.47061916
NSC 310547 Null 0.0435808621943462 0.4785816
Total:92  Current:87    [First] [Prev] [Next] [Last]